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First discovered... AMP-
activated protein kinase (AMPK)
was first named in 1988 although
it had appeared in several earlier
reports under a number of
different aliases, e.g. HMG-CoA
reductase kinase, acetyl-CoA
carboxylase kinase. The name
AMP-activated protein kinase was
chosen after one of its
physiological activators, AMP.
Don’t ever say... Cyclic-AMP
dependent protein kinase in the
same breath! AMPK and PKA
may have similar-sounding
names but they are regulated by
different pathways and their
downstream effects, although in
some cases overlap, are quite
distinct.
What does it do? AMPK has
been dubbed the cellular fuel
gauge, because it is activated by a
drop in the energy status of the
cell. If ATP is used up faster than
it can be re-synthesized, ATP
levels fall and this leads to a rise
in AMP. The increase in the
AMP:ATP ratio triggers the
activation of AMPK and leads to
the phosphorylation of a large
number of downstream targets.
The overall effect of AMPK
activation is to switch off energy-
using pathways and switch on
energy-generating pathways, thus
helping to restore the energy
balance within the cell. The
conservation of AMPK throughout
evolution emphasises its
importance: homologs have been
identified in all eukaryotic species
examined to date, including
plants. More recent findings have
shown that AMPK is activated by
stimuli that do not cause a change
in the AMP:ATP ratio, such as
hyperosmotic stress, indicating
that the kinase may have other
roles within the cell.
What does it look like? AMPK is
a heterotrimeric enzyme complex.
The α subunit contains a typical
serine/threonine kinase domain
and a carboxy-terminal regulatory
domain. The β subunit acts as a
scaffold for binding the other two
subunits and contains a glycogen-
binding domain. The γ subunit
contains four cystathionine-β-
synthase (CBS) domains that play
a role in binding AMP and ATP,
allosteric effectors of the kinase. A
range of isoforms of each of the
subunits results in 12 possible
combinations of the heterotrimeric
complex in mammals. The
physiological role of the different
isoforms is not clear, although
their differing tissue distributions
suggest they have distinct roles in
specific cells.
How is it regulated? Activation
of AMPK requires phosphorylation
by an upstream kinase, which was
recently identified as LKB1.
Intriguingly, inactivating mutations
in LKB1 cause a rare form of
hereditary cancer, called Peutz-
Jeghers syndrome. It is not yet
clear whether AMPK is involved in
the progression of this disease,
but it does hint at the possibility
that AMPK may be involved in cell
proliferation.
Can we live without it? Almost
certainly not. Mice lacking either
one of the catalytic α subunits are
viable, but deleting both isoforms
results in embryonic lethality.
Interestingly, mice lacking LKB1
also die at around the same stage
during development. Although a
complete loss of AMPK activity is
lethal, subtle changes in AMPK
activity can lead to serious clinical
consequences. Naturally
occurring mutations within the γ2
regulatory subunit in humans
cause cardiac hypertrophy
associated with a form of
arrhythmia known as
Wolff–Parkinson–White syndrome,
possibly by abolishing the normal
activation of the kinase by AMP.
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Figure 1. Role of AMPK in the regulation of intracellular energy metabolism.
AMPK is activated by a rise in the AMP:ATP ratio, e.g. in response to anoxia, which occurs
following a drop in the ATP concentration as a consequence of the reaction catalysed by
adenylate kinase. AMPK is also activated by a nucleotide-independent mechanism e.g.
following hyperosmotic stress, but in this case the signal is unknown. In both cases, acti-
vation of AMPK requires phosphorylation of threonine 172 (T172) within the α subunit,
catalysed by LKB1. Once activated, AMPK increases energy supply by switching on ATP-
generating pathways and decreases energy demand by switching off ATP-using path-
ways. AMPK also has longer-term effects altering gene and protein expression. These
combined roles of AMPK ensure that the energy status of the cell is finely balanced.
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